BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12085194)

  • 1. Oleuropein Induces Cytotoxicity and Peroxiredoxin Over-expression in MCF-7 Human Breast Cancer Cells.
    Junkins K; Rodgers M; Phelan SA
    Anticancer Res; 2023 Oct; 43(10):4333-4339. PubMed ID: 37772594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3): Unraveling the Role in Mediating IGF-Independent Effects Within the Cell.
    Varma Shrivastav S; Bhardwaj A; Pathak KA; Shrivastav A
    Front Cell Dev Biol; 2020; 8():286. PubMed ID: 32478064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin may protect nondiabetic breast cancer women from metastasis.
    El-Haggar SM; El-Shitany NA; Mostafa MF; El-Bassiouny NA
    Clin Exp Metastasis; 2016 Apr; 33(4):339-57. PubMed ID: 26902691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of insulin-like growth factor binding protein-3 (IGFBP-3) in cancer.
    Perks CM; Holly JM
    J Cell Commun Signal; 2015 Jun; 9(2):159-66. PubMed ID: 25920743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?
    Zielinska HA; Bahl A; Holly JM; Perks CM
    Breast Cancer (Dove Med Press); 2015; 7():9-19. PubMed ID: 25632238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in IGF-axis protein expression and survival among multiethnic breast cancer patients.
    Hernandez BY; Wilkens LR; Le Marchand L; Horio D; Chong CD; Loo LW
    Cancer Med; 2015 Mar; 4(3):354-62. PubMed ID: 25619494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF binding proteins in cancer: mechanistic and clinical insights.
    Baxter RC
    Nat Rev Cancer; 2014 May; 14(5):329-41. PubMed ID: 24722429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice.
    Roberti MP; Arriaga JM; Bianchini M; Quintá HR; Bravo AI; Levy EM; Mordoh J; Barrio MM
    Cancer Biol Ther; 2012 Sep; 13(11):1123-40. PubMed ID: 22825326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic, Pro-Apoptotic Effects of IGFBP-3 on Breast Cancer Cells are Reversible: Involvement of PKA, Rho, and Ceramide.
    Perks CM; Burrows C; Holly JM
    Front Endocrinol (Lausanne); 2011; 2():13. PubMed ID: 22654794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGFBP-3 can either inhibit or enhance EGF-mediated growth of breast epithelial cells dependent upon the presence of fibronectin.
    McIntosh J; Dennison G; Holly JM; Jarrett C; Frankow A; Foulstone EJ; Winters ZE; Perks CM
    J Biol Chem; 2010 Dec; 285(50):38788-800. PubMed ID: 20851879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF binding proteins (IGFBPs) and regulation of breast cancer biology.
    Perks CM; Holly JM
    J Mammary Gland Biol Neoplasia; 2008 Dec; 13(4):455-69. PubMed ID: 19031049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.
    Vestey SB; Perks CM; Sen C; Calder CJ; Holly JM; Winters ZE
    Breast Cancer Res; 2005; 7(1):R119-29. PubMed ID: 15642160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A non-IGF binding mutant of IGFBP-3 modulates cell function in breast epithelial cells.
    Perks CM; McCaig C; Clarke JB; Clemmons DR; Holly JM
    Biochem Biophys Res Commun; 2002 Jun; 294(5):988-94. PubMed ID: 12074574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
    Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression.
    Levitt RJ; Buckley J; Blouin MJ; Schaub B; Triche TJ; Pollak M
    Biochem Biophys Res Commun; 2004 Apr; 316(2):421-8. PubMed ID: 15020235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of insulin-like growth factor binding protein-3 in breast cancer cell growth.
    Schedlich LJ; Graham LD
    Microsc Res Tech; 2002 Oct; 59(1):12-22. PubMed ID: 12242693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis.
    Fynan TM; Reiss M
    Crit Rev Oncog; 1993; 4(5):493-540. PubMed ID: 8241322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells.
    McCaig C; Fowler CA; Laurence NJ; Lai T; Savage PB; Holly JM; Perks CM
    Br J Cancer; 2002 Jun; 86(12):1963-9. PubMed ID: 12085194
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.